The Recall Desk
ModerateFDA (Devices)·Z-0929-2021·Announced 2021-02-03

Neocis Anterior Chairside Splints Recalled for Potential Mislabeling

Neocis, Inc. is recalling 100 units of Gen 2 Anterior Chairside Splints due to potential mislabeling. The affected units were distributed to facilities in seven states.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard is limited to potential mislabeling without reported injuries or illnesses, fitting the criteria for a moderate severity score.

Plain-English summary

Neocis, Inc. is recalling 100 units of the DRW-0739-01:Gen 2 Anterior Chairside Splint LRUL (lower right-upper left). These accessories are part of the Neocis Guidance System (NGS). The recall is associated with Work Order (Lot) Number 1573.

The recall was initiated because the LRUL and LLUR posterior chairside splints and the LLUR anterior chairside splints may be mislabeled. The affected units were distributed to facilities in Ohio, Florida, Connecticut, Massachusetts, Arizona, Pennsylvania, and New York.

Healthcare facilities should check their inventory for the specific lot number and product description. If the affected units are found, they should be removed from use and returned to Neocis, Inc. according to the company's instructions.

The recalled product

Product
DRW-0739-01:Gen 2 Anterior Chairside Splint LRUL (lower right-upper left); accessories to the parent system, the Neocis Guidance System (NGS)
Manufacturer
Neocis, Inc.
Affected units
100

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Work Order (Lot) Number 1573

Distribution

Distributed in 7 states: